Post embolisation syndrome: Which Medications Cause It? (93 Reports Across 10 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Post embolisation syndrome has been reported as an adverse event with 10 different drugs in the FDA's FAERS database, with 93 total reports. 11 of these reports resulted in death.The drugs most commonly associated with Post embolisation syndrome are EPIRUBICIN, DOXORUBICIN, and ETHIODIZED OIL.
93
Total Reports
10
Drugs Involved
11
Deaths
29
Hospitalizations
57.9 yrs
Average Patient Age
36.2% / 63.8%
Female / Male
Which Drugs Cause Post embolisation syndrome Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| EPIRUBICIN | 31 | 0.2% | 5 | 4 | 0 |
| DOXORUBICIN | 26 | 0.0% | 4 | 14 | 0 |
| ETHIODIZED OIL | 24 | 2.4% | 1 | 9 | 0 |
| GELATIN | 21 | 17.4% | 4 | 0 | 0 |
| IODIZED OIL | 21 | 65.6% | 4 | 0 | 0 |
| 10-HYDROXYCAMPTOTHECIN | 20 | 60.6% | 4 | 0 | 0 |
| OXALIPLATIN | 11 | 0.0% | 0 | 1 | 0 |
| BEVACIZUMAB | 6 | 0.0% | 1 | 1 | 0 |
| MITOMYCIN | 6 | 0.3% | 0 | 4 | 0 |
| CAMRELIZUMAB | 5 | 1.2% | 4 | 0 | 0 |